Search Results - "Nasserinejad, Kazem"

Comparison of Criteria for Choosing the Number of Classes in Bayesian Finite Mixture Models by Nasserinejad, Kazem, van Rosmalen, Joost, de Kort, Wim, Lesaffre, Emmanuel

“…Identifying the number of classes in Bayesian finite mixture models is a challenging problem. Several criteria have been proposed, such as adaptations of the…”
Get full text

Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis by Croles, F Nanne, Nasserinejad, Kazem, Duvekot, Johannes J, Kruip, Marieke Jha, Meijer, Karina, Leebeek, Frank Wg

“… To provide evidence to support updated guidelines for the management of pregnant women with hereditary thrombophilia in order to reduce the risk of a first…”
Get full text

Integrating latent classes in the Bayesian shared parameter joint model of longitudinal and survival outcomes by Andrinopoulou, Eleni-Rosalina, Nasserinejad, Kazem, Szczesniak, Rhonda, Rizopoulos, Dimitris

“…Cystic fibrosis is a chronic lung disease requiring frequent lung-function monitoring to track acute respiratory events (pulmonary exacerbations). The…”
Get full text

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial by Minnema, Monique C, Nasserinejad, Kazem, Hazenberg, Bouke, Hegenbart, Ute, Vlummens, Philip, Ypma, Paula F, Kröger, Nicolaus, Wu, Ka Lung, Kersten, Marie Jose, Schaafsma, M Ron, Croockewit, Sandra, de Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemieke, Koene, Harry, Bos, Gerard, Sonneveld, Pieter, Schönland, Stefan

“…This prospective, multicenter, phase II study investigated the use of four cycles of bortezomib-dexamethasone induction treatment, followed by high-dose…”
Get full text

T2 mapping of the meniscus is a biomarker for early osteoarthritis by Eijgenraam, Susanne M., Bovendeert, Frans A. T., Verschueren, Joost, van Tiel, Jasper, Bastiaansen-Jenniskens, Yvonne M., Wesdorp, Marinus A., Nasserinejad, Kazem, Meuffels, Duncan E., Guenoun, Jamal, Klein, Stefan, Reijman, Max, Oei, Edwin H. G.

“…Purpose To evaluate in vivo T 2 mapping as quantitative, imaging-based biomarker for meniscal degeneration in humans, by studying the correlation between T 2…”
Get full text

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA by Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., Jonge, Evert, Dinjens, Winand N. M., Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.

“…Here, we compare the number of mutant molecules and the variant allele frequency as units of measurement for circulating tumor DNA. We conclude that when using…”
Get full text

Effects of nongenetic factors on immune cell dynamics in early childhood: The Generation R Study by van den Heuvel, Diana, PhD, Jansen, Michelle A.E., MD, Nasserinejad, Kazem, MSc, Dik, Willem A., PhD, van Lochem, Ellen G., PhD, Bakker-Jonges, Liesbeth E., PhD, Bouallouch-Charif, Halima, BSc, Jaddoe, Vincent W.V., MD, PhD, Hooijkaas, Herbert, PhD, van Dongen, Jacques J.M., MD, PhD, Moll, Henriëtte A., MD, PhD, van Zelm, Menno C., PhD

“…Background Numbers of blood leukocyte subsets are highly dynamic in childhood and differ greatly between subjects. Interindividual variation is only partly…”
Get full text

Improving the identification of frail elderly newly diagnosed multiple myeloma patients by Stege, Claudia A. M., Nasserinejad, Kazem, Klein, Saskia K., Timmers, Gert-Jan, Hoogendoorn, Mels, Ypma, Paula F., Nijhof, Inger S., Velders, Gerjo A., Strobbe, Leonie, Durdu-Rayman, Nazik, Westerman, Matthijs, Davidis-van Schoonhoven, Marjan A., van Kampen, Roel J. W., Beeker, Aart, Koster, Ad, Dijk, Amanda C., van de Donk, Niels W. C. J., van der Spek, Ellen, Leys, Rineke B. L., Silbermann, Matthijs H., Groen, Kaz, van der Burg-de Graauw, Nicole C. H. P., Sinnige, Harm A. M., van der Hem, Klaas G., Levenga, Henriette, Bilgin, Yavuz M., Sonneveld, Pieter, Levin, Mark-David, Zweegman, Sonja

Get full text

Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations by Levin, Mark-David, Kater, Arnon, Mattsson, Mattias, Kersting, Sabina, Ranti, Juha, Thi Tuyet Tran, Hoa, Nasserinejad, Kazem, Niemann, Carsten Utoft

“…IntroductionLiterature is scarce on the combination treatment of ibrutinib and venetoclax (IV) is scarce in relapsed or refractory chronic lymphocytic…”
Get full text

Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial by van der Maas, Niek G., Versluis, Jurjen, Nasserinejad, Kazem, van Rosmalen, Joost, Pabst, Thomas, Maertens, Johan, Breems, Dimitri, Manz, Markus, Cloos, Jacqueline, Ossenkoppele, Gert J., Floisand, Yngvar, Gradowska, Patrycja, Löwenberg, Bob, Huls, Gerwin, Postmus, Douwe, Pignatti, Francesco, Cornelissen, Jan J.

“…Randomized controlled trials (RCTs) are the gold standard to establish the benefit-risk ratio of novel drugs. However, the evaluation of mature results often…”
Get full text

Carfilzomib, Pomalidomide, and Dexamethasone As Second‐line Therapy for Lenalidomide‐refractory Multiple Myeloma by Sonneveld, Pieter, Zweegman, Sonja, Cavo, Michele, Nasserinejad, Kazem, Broijl, Annemiek, Troia, Rosella, Pour, Ludek, Croockewit, Sandra, Corradini, Paolo, Patriarca, Francesca, Wu, Kalung, Droogendijk, Jolanda, Bos, Gerard, Hajek, Roman, Teresa Petrucci, Maria, Ypma, Paula, Zojer, Nicholas, Minnema, Monique C., Boccadoro, Mario

“…This phase 2 trial investigated reinduction with carfilzomib, pomalidomide, and dexamethasone (KPd) and continuous pomalidomide/dexamethasone in patients at…”
Get full text

P899: HOVON 104; LONG TERM FOLLOW‐UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS by Minnema, Monique, Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula, Lung Wu, Ka, José Kersten, Marie, Croockewit, Sandra, Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemiek, Schönland, Stefan

Get full text

HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients by Minnema, Monique C., Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula F., Wu, Ka Lung, Kersten, Marie Jose, Croockewit, Sandra, Zweegman, Sonja, Tick, Lidwine, Broijl, Annemiek, Koene, Harry, Bos, Gerard M. J., Sonneveld, Pieter, Schönland, Stefan O.

“…The HOVON 104 studied bortezomib‐dexamethasone induction therapy and autologous stem cell transplantation in 50 patients, of whom 35 received an autologous…”
Get full text

P634: EARLY‐STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA by Hengeveld, Paul, Schilperoord‐Vermeulen, Joyce, Klift, Michèle, Dubois, Julie, Martijn Kolijn, Pieter, Kavelaars, François, Rijken, Melissa, Dobber, Johan, Nasserinejad, Kazem, Kersting, Sabina, Westerweel, Peter, Kater, Arnon, Langerak, Anton, Levin, Mark‐David

Get full text

S148: TIME‐LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4‐YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL by Kater, Arnon, Dubois, Julie, Brieghel, Christian, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit, Mous, Rogier, Mellink, Clemens, Dobber, Johan, Poulsen, Christian, Da Cunha‐Bang, Caspar, Fredriksen, Hendrik, Janssens, Ann, Schjodt, Ida, Dompeling, Ellen, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa, Nasserinejad, Kazem, Levin, Mark‐David, Niemann, Carsten

Get full text

Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes by Groen, Kazimierz, Smits, Febe, Nasserinejad, Kazem, Levin, Mark‐David, Regelink, Josien C., Timmers, Gert‐Jan, Waal, Esther G. M., Westerman, Matthijs, Velders, Gerjo A., Heer, Koen, Leys, Rineke B. L., Kampen, Roel J. W., Stege, Claudia A. M., Seefat, Maarten R., Nijhof, Inger S., Spek, Ellen, Klein, Saskia K., Donk, Niels W. C. J., Ypma, Paula F., Zweegman, Sonja

Get full text

Comparison of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis by Ling, Sui Wai, de Jong, Anouk C., Schoots, Ivo G., Nasserinejad, Kazem, Busstra, Martijn B., van der Veldt, Astrid A.M., Brabander, Tessa

“…In December 2020, the US Food and Drug Administration approved a 68Ga-labeled prostate-specific membrane antigen ligand (68Ga-PSMA-11) for positron emission…”
Get full text

P877: IXAZOMIB DARATUMUMAB AND LOW‐DOSE DEXAMETHASONE IN INTERMEDIATE‐FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY by Groen, Kaz, Stege, Claudia, Nasserinejad, Kazem, Heer, Koen, Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka‐Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie‐Christiane, Donk, Niels W.C.J., Timmers, Gert‐Jan, Boer, Fransien, Tick, Lidwine W., Spek, Ellen, Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., Levin, Mark‐David, Ypma, Paula F., Zweegman, Sonja

Get full text

Calibrating Doppler imaging of preterm intracerebral circulation using a microvessel flow phantom by Camfferman, Fleur A, Ecury-Goossen, Ginette M, La Roche, Jhuresy E, de Jong, Nico, van 't Leven, Willem, Vos, Hendrik J, Verweij, Martin D, Nasserinejad, Kazem, Cools, Filip, Govaert, Paul, Dudink, Jeroen

“…Preterm infants are born during critical stages of brain development, in which the adaptive capacity of the fetus to extra-uterine environment is limited…”
Get full text

Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: Objective airway-artery quantification by Kuo, Wieying, de Bruijne, Marleen, Petersen, Jens, Nasserinejad, Kazem, Ozturk, Hadiye, Chen, Yong, Perez-Rovira, Adria, Tiddens, Harm A. W. M.

“…Objectives To quantify airway and artery (AA)-dimensions in cystic fibrosis (CF) and control patients for objective CT diagnosis of bronchiectasis and airway…”
Get full text